Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03640884
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:06.612962+00:00
Published At
2021-07-07T00:00:00+00:00
Record Updated At
2021-07-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adverse Drug Event", "Adverse Drug Reactions", "Anaphylactic Reaction", "Severe Adverse Reactions"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-07-07"
protocolSection.identificationModule.nctId
"NCT03640884"
protocolSection.identificationModule.officialTitle
"Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adverse Drug Event (protocolSection.conditionsModule.conditions)
  • Adverse Drug Reactions (protocolSection.conditionsModule.conditions)
  • Anaphylactic Reaction (protocolSection.conditionsModule.conditions)
  • Severe Adverse Reactions (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.